Clinical Trial Update: Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by NIDA comparing cannabidiol (CBD) with delta-9-tetrahydrocannabinol (THC) and alprazolam for Cannabis Use Disorder has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Alprazolam (alprazolam)
• Cannabidiol (CBD) (cannabidiol)
• Delta-9-tetrahydrocannabinol (THC) (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis Use Disorder | Phase 1 | Status: COMPLETED